Michael D. Nissen - Infectious Diseases

Author Information

Michael D. Nissen is a distinguished researcher affiliated with the Queensland Paediatric Infectious Diseases Clinical Trials Centre at the Royal Children's Hospital and Children's Health Queensland, located in Brisbane, QLD, Australia. His work primarily focuses on infectious diseases, with a particular interest in vaccine-preventable diseases and the epidemiology of bacterial and viral infections.

Research Contributions

Michael D. Nissen has made substantial contributions to the field of infectious diseases through his extensive research on vaccine-preventable diseases, including meningococcal and Haemophilus influenzae type b (Hib) infections. His research has explored the efficacy of vaccines such as the 4-component vaccine 4CMenB and the DTPa-HBV-IPV/Hib vaccine in Australian populations. Additionally, he has investigated the impact of the COVID-19 pandemic on infectious disease patterns and vaccine development. Nissen's work is instrumental in understanding the distribution of otopathogens in children and improving disease surveillance, as exemplified by his studies on Q fever in Queensland.

Aliases

Michael D. Nissen is also known by several aliases, including Michael Nissen, M D Nissen, M Nissen, M. Nissen, and M. D. Nissen. These variations are commonly used across his publications and professional citations.

Publication and Citation Metrics

Metric	Value
Total Papers	239
Total Citations	9720
h-index	57

Publications:

The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook.

DOI: 10.5694/mja2.51463

Year: 2022

Predominant Bacterial and Viral Otopathogens Identified Within the Respiratory Tract and Middle Ear of Urban Australian Children Experiencing Otitis Media Are Diversely Distributed

DOI: 10.3389/fcimb.2022.775535

Year: 2022

High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS

DOI: 10.1080/21645515.2021.1904758

Year: 2021

COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control

DOI: 10.1016/j.ijid.2021.09.045

Year: 2021

University of Groningen Single cell transcriptome analysis reveals disease-defining T cell subsets in the tumor microenvironment of classic Hodgkin lymphoma Aoki,

DOI:

Year: 2020

The improving state of Q fever surveillance. A review of Queensland notifications, 2003-2017.

DOI: 10.33321/cdi.2020.44.48

Year: 2020

[Diagnosis and treatment of non-infectious uveitis associated with systemic disease: a guide for internists].

DOI:

Year: 2020

Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication

DOI: 10.1080/14760584.2020.1825948

Year: 2020

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine

DOI: 10.1080/21645515.2020.1764826

Year: 2020

Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis

DOI: 10.1080/21645515.2020.1780848

Year: 2020

How Do Aedes Mosquitoes Transmit Diseases?

What is the future of RT-PCR in Infectious Diseases?

What are the Objectives of the RBM Partnership?

How Does Inherited Immunity Work?

What are Healthcare Associated Infections (HAIs)?

Which Infectious Diseases Are Common Culprits?

What are Aedes Mosquitoes?

What are Influenza Antivirals?

How Can We Improve Global Health Infrastructure to Combat Infectious Diseases?

How Do Infectious Diseases Spread in the One Health Context?

Partnered Content Networks

Relevant Topics